Fig. 2

Fracture risk among women in the non-treatment group*, stratified by low and high frailty.* The non-treatment group was identified using the Swedish Osteoporosis Foundation and include those with no previous MOFs and either a FRAX_MOF < 15% or did not meet requirements for treatment after BMD measurement (i.e. T-score < − 2.5 and FRAX_{MOF BMD} > 20%). Low frailty includes Q1-Q3 (FI 0.0–0.27) and high frailty Q4 (FI > 0.28)